Drugplain

GILTUSS DIABETIC EX 600 mg/1

GILTUSS DIABETIC EX · TABLET · Gil Pharmaceutical Corp

No Recall History
Plain English

GILTUSS DIABETIC EX is a tablet containing giltuss diabetic ex at 600 mg/1, taken oral. Manufactured by Gil Pharmaceutical Corp.

Key Facts

Brand Name
GILTUSS DIABETIC EX
Generic Name
GILTUSS DIABETIC EX
NDC Code (Product)
58552-339
Manufacturer
Gil Pharmaceutical Corp
Strength
600 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
M012
Drug Class
Expectorant [EPC]
Marketing Start
10/07/2025

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and helps make cough more productive.

Dosage & Administration

Directions do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 or 2 tablets every 12 hours do not exceed 4 tablets in 24 hours children under 12 years of age: do not use

Warnings

Warnings Do not use for children under 12 years

Frequently Asked Questions

What is GILTUSS DIABETIC EX used for?

GILTUSS DIABETIC EX contains GILTUSS DIABETIC EX. It is a tablet taken oral. Consult your doctor for specific uses.

Is GILTUSS DIABETIC EX a controlled substance?

GILTUSS DIABETIC EX is not classified as a controlled substance by the DEA.

What is the generic name for GILTUSS DIABETIC EX?

The generic name for GILTUSS DIABETIC EX is GILTUSS DIABETIC EX. There are no other listed brand versions of GILTUSS DIABETIC EX.

What is the NDC code for GILTUSS DIABETIC EX 600 mg/1?

The NDC (National Drug Code) for GILTUSS DIABETIC EX 600 mg/1 is 58552-339, listed by Gil Pharmaceutical Corp.

Product NDC

58552-339

Package NDC

58552-339-07

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)